MYGN vs RIVN · rev $824.5M vs rev $1.66B
Myriad Genetics Inc (MYGN) versus Rivian Automotive Inc (RIVN) — a side-by-side from cached financials, not a winner call.
Myriad Genetics Inc (MYGN) is a diagnostics & research company listed on NASDAQ.
Rivian Automotive Inc (RIVN) is a auto manufacturers company listed on NASDAQ. It is led by Robert Joseph Scaringe Ph.D..
Latest reported MYGN revenue for 2025-12-31 was $824.5M. Net income was -$365.9M. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. MYGN currently screens at market cap $413.7M.
Latest reported RIVN revenue for 2026-06-30 was $1.66B. Net income was -$833.0M. Revenue was up 20.1% from 2026-03-31 to 2026-06-30. RIVN currently screens at market cap $21.81B.
MYGN currently screens at market cap $413.7M. RIVN currently screens at market cap $21.81B.
Not investment advice. Open the MYGN and RIVN stock pages for the full models.
Not investment advice.